Вы находитесь на странице: 1из 304

Definition Of Stroke

Rapidly developed clinical sign of focal disturbance of cerebral function of presumed vascular origin and of more than 24 hours WHO TIA (Transient Ischemic Attack) recovery is complete within 24 hours. 10% of patients will go on to have a stroke.

11/07/11

MUN FP Academic Half Day

Sub-types Of Stroke

Ischemic obstruction to one of major cerebral arteries, brainstem strokes are less common. Haemorrhage 9% are caused by haemorrhage to the deep parts of the brain. Patients are usually hypertensive.

11/07/11

MUN FP Academic Half Day

Common Causes
Thrombosis
Lacunar stroke (small vessel) Large vessel thrombosis Dehydration

11/07/11

MUN FP Academic Half Day

Causes of Ischemic Stroke

Embolic occlusion Artery-to-artery Carotid bifurcation Aortic arch Arterial dissection

11/07/11

MUN FP Academic Half Day

Cardio embolic causes of Ischemic Stroke


Atrial

fibrillation Mural thrombus Myocardial infarction Dilated cardiomyopathy Valvular lesions Mitral stenosis Mechanical valve Bacterial endocarditis

11/07/11

MUN FP Academic Half Day

Causes of Ischemic Stroke


Paradoxical

embolus Atrial septal defect Patent foramen ovale Atrial septal aneurysm Spontaneous echo contrast

11/07/11

MUN FP Academic Half Day

Uncommon Causes
Hypercoaguable

disorders Protein C deficiency Protein S deficiency Antithrombin III deficiency Antiphospholipid syndrome Factor V Leiden mutationa Prothrombin G20210 mutationa Systemic malignancy

11/07/11

MUN FP Academic Half Day

Uncommon Causes
Sickle cell anemia -Thalassemia Polycythemia vera Systemic lupus erythematosus Homocysteinemia Thrombotic thrombocytopenic purpura Disseminated intravascular coagulation Dysproteinemias Nephrotic syndrome Inflammatory bowel disease Oral contraceptives

11/07/11

MUN FP Academic Half Day

Uncommon Causes
Venous sinuous thrombosis Fibro muscular dysplasia Vasculitis

Systemic vasculitis (PAN, Wegener's, Takayasu's, giant cell arteritis) Primary CNS vasculitis Meningitis (syphilis, tuberculosis, fungal, bacterial, zoster)

11/07/11

MUN FP Academic Half Day

Uncommon Causes

Cardiogenic
Mitral valve calcification Atrial myxoma Intracardiac tumor Marantic endocarditis Libman-Sacks endocarditis

Subarachnoid hemorrhage vasospasm Drugs: cocaine, amphetamine Moyamoya disease Eclampsia

11/07/11

MUN FP Academic Half Day

10

Fibro muscular dysplasia


Affects the cervical arteries and occurs mainly in women. The carotid or vertebral arteries show multiple rings of segmental narrowing alternating with dilatation. Occlusion is usually incomplete. The process is often asymptomatic but occasionally is associated with an audible bruit, TIAs, or stroke. Involvement of the renal arteries is common and may result in hypertension.
MUN FP Academic Half Day 11

11/07/11

Moyamoya disease

Occlusive disease Large intracranial arteries, especially the distal internal carotid artery and the stem of the MCA and ACA Vascular inflammation is absent. "Puff of smoke" (moyamoya in Japanese) on conventional x-ray angiography.

11/07/11

MUN FP Academic Half Day

12

"Puff of smoke" (moyamoya in Japanese)

The lenticulostriate arteries develop a rich collateral circulation around the occlusive lesion, which gives the impression of a "Puff of smoke" (Moyamoya in Japanese) Other collaterals include Transdural anastomoses between the cortical surface branches of the meningeal and scalp arteries.
MUN FP Academic Half Day 13

11/07/11

AVMs

AVMs occur in all parts of the cerebral hemispheres, brainstem, and spinal cord, Largest ones are most frequently in the posterior half of the hemispheres, commonly forming a wedge-shaped lesion extending from the cortex to the ventricle. Present from birth in most patients,

11/07/11

MUN FP Academic Half Day

14

Bleeding or other symptoms

Most common between the ages of 10 and 30, occasionally as late as the fifties. AVMs are more frequent in men, and rare familial cases have been described.

11/07/11

MUN FP Academic Half Day

15

AVMs

Headache (without bleeding) may be hemicranial and throbbing, like migraine, or diffuse. Focal seizures, with or without generalization, occur in ~30% of cases. Half of AVMs become evident as intracerebral hemorrhages. In most, the hemorrhage is mainly intraparenchymal with extension into the subarachnoid space in some cases.

11/07/11

MUN FP Academic Half Day

16

AVMs complications

The risk of rerupture is ~24% per year and is particular high in the first few weeks. Hemorrhages may be massive, leading to death, or may be as small as 1 cm in diameter, leading to minor focal symptoms or no deficit.

11/07/11

MUN FP Academic Half Day

17

steal blood

The AVM may be large enough to steal blood away from adjacent normal brain tissue or to increase venous pressure significantly to produce venous ischemia locally and in remote areas of the brain. This is seen most often with large AVMs in the territory of the MCA.

11/07/11

MUN FP Academic Half Day

18

Large AVMs of the anterior circulation

Systolic and diastolic bruit (sometimes self-audible) over the eye, forehead, or neck Bounding carotid pulse.

11/07/11

MUN FP Academic Half Day

19

Silent

Headache at the onset of AVM rupture is not generally as explosive as with aneurysmal rupture.

11/07/11

MUN FP Academic Half Day

20

Imageology

MRI is better than CT for diagnosis, although noncontrast CT scanning sometimes detects calcification of the AVM and contrast may demonstrate the abnormal blood vessels.

11/07/11

MUN FP Academic Half Day

21

Future

The impact of recurrent hemorrhage on disability is relatively modest, so the indication for Surgery in asymptomatic AVMs is debated A large-scale randomized trial is currently addressing this question.
MUN FP Academic Half Day 22

11/07/11

11/07/11

MUN FP Academic Half Day

23

11/07/11

MUN FP Academic Half Day

24

11/07/11

MUN FP Academic Half Day

25

11/07/11

MUN FP Academic Half Day

26

11/07/11

MUN FP Academic Half Day

27

11/07/11

MUN FP Academic Half Day

28

11/07/11

MUN FP Academic Half Day

29

11/07/11

MUN FP Academic Half Day

30

FIGURE 3.11. Non-contrast brain CT scan showing massive intraventricular haemorrhage with hydrocephalus as well as widespread subarachnoid haemorrhage. The patient was aged 45 years and suddenly slumped on top of his wife during intercourse.

11/07/11

MUN FP Academic Half Day

31

11/07/11

MUN FP Academic Half Day

32

FIGURE 3.15. Digital subtraction angiogram showing a left middle cerebral artery aneurysm (arrow).

11/07/11

MUN FP Academic Half Day

33

11/07/11

MUN FP Academic Half Day

34

CT scan of a 31-year-old male with sud- den right hemiplegia and altered level of consciousness, showing a large left basal ganglia/internal capsular haemorrhage. Note the movement artefacts as the patient was restless and not fully co-operative.

11/07/11

MUN FP Academic Half Day

35

11/07/11

MUN FP Academic Half Day

36

Medial
PMB of upper basilar and proximal Posterior Cerebral Artery PMB of UBA PMB of MBA PMB of basilar artery Occlusion of VA or of branch of vertebral or LBA
MUN FP Academic Half Day 37

11/07/11

Lateral
Small penetrating arteries arising from PCA Syndrome of superior Cerebellar artery SCFA (short circumferential artery) AICA PICA, Superior, middle, or inferior branches of lateral medullary artery, vertebral artery

11/07/11

MUN FP Academic Half Day

38

Midbrain syndrome:
Medial Paramedian branches of upper basilar and proximal posterior cerebral arteries Lateral Syndrome of small penetrating arteries arising from posterior cerebral artery
11/07/11 MUN FP Academic Half Day 39

Superior pontine syndrome

Medial (paramedian branches of upper basilar artery) Lateral (syndrome of superior Cerebellar artery)

11/07/11

MUN FP Academic Half Day

40

Middle pontine syndrome

Medial midpontine syndrome (paramedian branch of midbasilar artery) Lateral midpontine syndrome (short circumferential artery)

11/07/11

MUN FP Academic Half Day

41

Inferior pontine syndrome

Medial (occlusion of paramedian branch of basilar artery) Lateral (occlusion of anterior inferior Cerebellar artery)

11/07/11

MUN FP Academic Half Day

42

Medullary syndrome

Medial (occlusion of vertebral artery or of branch of vertebral or lower basilar artery) Lateral (occlusion of any of five vessels may be responsible vertebral, posterior inferior Cerebellar, superior, middle, or inferior lateral medullary arteries)

11/07/11

MUN FP Academic Half Day

43

IPSILATERAL

Medial midbrain syndrome (paramedian branches of upper basilar and proximal posterior cerebral arteries) Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers

11/07/11

MUN FP Academic Half Day

44

Lateral midbrain syndrome

Lateral midbrain syndrome (syndrome of small penetrating arteries arising from posterior cerebral artery) Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers and/or third nerve nucleus On side opposite lesion Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

11/07/11

MUN FP Academic Half Day

45

IPSILATERAL (medial syndromes)

Medial midbrain syndrome (paramedian branches of upper basilar and proximal posterior cerebral arteries) Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers

11/07/11

MUN FP Academic Half Day

46

IPSILATERAL (medial syndromes)

Medial superior pontine syndrome (paramedian branches of upper basilar artery) Cerebellar ataxia (probably): Superior and/or middle Cerebellar peduncle Internuclear ophthalmoplegia: Medial longitudinal fasciculus Myoclonic syndrome, palate, pharynx, vocal cords, respiratory apparatus, face, oculomotor apparatus, etc.: Localization uncertaincentral tegmental bundle, dentate projection, inferior olivary nucleus

11/07/11

MUN FP Academic Half Day

47

IPSILATERAL (medial syndromes)

Medial midpontine syndrome (paramedian branch of midbasilar artery) Ataxia of limbs and gait (more prominent in bilateral involvement): Pontine nuclei

11/07/11

MUN FP Academic Half Day

48

IPSILATERAL (medial syndromes)

Medial inferior pontine syndrome (occlusion of paramedian branch of basilar artery) Paralysis of conjugate gaze to side of lesion (preservation of convergence): Center for conjugate lateral gaze Nystagmus: Vestibular nucleus Ataxia of limbs and gait: Likely middle Cerebellar peduncle Diplopia on lateral gaze: Abducens nerve

11/07/11

MUN FP Academic Half Day

49

IPSILATERAL (medial syndromes)

Medial medullary syndrome (occlusion of vertebral artery or of branch of vertebral or lower basilar artery) Paralysis with atrophy of half the tongue: Ipsilateral twelfth nerve

11/07/11

MUN FP Academic Half Day

50

IPSILATERAL (lateral syndromes)

Lateral midbrain syndrome (syndrome of small penetrating arteries arising from posterior cerebral artery) Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers and/or third nerve nucleus On side opposite lesion Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

11/07/11

MUN FP Academic Half Day

51

IPSILATERAL (lateral syndromes)

Lateral superior pontine syndrome (syndrome of superior Cerebellar artery) Ataxia of limbs and gait, falling to side of lesion: Middle and superior Cerebellar peduncles, superior surface of cerebellum, dentate nucleus Dizziness, nausea, vomiting; horizontal nystagmus: Vestibular nucleus
MUN FP Academic Half Day 52

11/07/11

Lateral superior pontine syndrome (syndrome of superior Cerebellar artery)

Paresis of conjugate gaze (ipsilateral): Pontine contralateral gaze Skew deviation: Uncertain Miosis, ptosis, decreased sweating over face (Horner's syndrome): Descending sympathetic fibers Tremor: Localization unclear Dentate nucleus, superior cerebellar peduncle

11/07/11

MUN FP Academic Half Day

53

IPSILATERAL (lateral syndromes)

Lateral midpontine syndrome (short circumferential artery) Ataxia of limbs: Middle Cerebellar peduncle Paralysis of muscles of mastication: Motor fibers or nucleus of fifth nerve Impaired sensation over side of face: Sensory fibers or nucleus of fifth nerve

11/07/11

MUN FP Academic Half Day

54

IPSILATERAL (lateral syndromes)

Lateral inferior pontine syndrome (occlusion of anterior inferior Cerebellar artery) Horizontal and vertical nystagmus, vertigo, nausea, vomiting, oscillopsia: Vestibular nerve or nucleus Facial paralysis: Seventh nerve
MUN FP Academic Half Day 55

11/07/11

Lateral inferior pontine syndrome (occlusion of anterior inferior Cerebellar artery)

Paralysis of conjugate gaze to side of lesion: Center for conjugate lateral gaze Deafness, tinnitus: Auditory nerve or cochlear nucleus Ataxia: Middle Cerebellar peduncle and Cerebellar hemisphere Impaired sensation over face: Descending tract and nucleus fifth nerve

11/07/11

MUN FP Academic Half Day

56

IPSILATERAL (lateral syndromes)

Lateral medullary syndrome (occlusion of any of five vessels may be responsiblevertebral, posterior inferior Cerebellar, superior, middle, or inferior lateral medullary arteries) Pain, numbness, impaired sensation over half the face: Descending tract and nucleus fifth nerve

11/07/11

MUN FP Academic Half Day

57

LMS

Ataxia of limbs, falling to side of lesion: Uncertainrestiform body, Cerebellar hemisphere, Cerebellar fibers, spinocerebellar tract (?) Nystagmus, diplopia, oscillopsia, vertigo, nausea, vomiting: Vestibular nucleus

11/07/11

MUN FP Academic Half Day

58

LMS

Horner's syndrome (miosis, ptosis, decreased sweating): Descending sympathetic tract Dysphagia, hoarseness, paralysis of palate, paralysis of vocal cord, diminished gag reflex: Issuing fibers ninth and tenth nerves Loss of taste: Nucleus and tractus solitarius

11/07/11

MUN FP Academic Half Day

59

LMS

Numbness of ipsilateral arm, trunk, or leg: Cuneate and gracile nuclei Weakness of lower face: Genuflected upper motor neuron fibers to ipsilateral facial nucleus

11/07/11

MUN FP Academic Half Day

60

CONTRALATERAL (medial syndromes)

11/07/11

MUN FP Academic Half Day

61

CONTRALATERAL (medial syndromes)

Medial midbrain syndrome (paramedian branches of upper basilar and proximal posterior cerebral arteries) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract descending in crus cerebri

11/07/11

MUN FP Academic Half Day

62

CONTRALATERAL (medial syndromes)

Medial superior pontine syndrome (paramedian branches of upper basilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected: Medial lemniscus

11/07/11

MUN FP Academic Half Day

63

CONTRALATERAL (medial syndromes)

Medial midpontine syndrome (paramedian branch of midbasilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus

11/07/11

MUN FP Academic Half Day

64

CONTRALATERAL (medial syndromes)

Medial inferior pontine syndrome (occlusion of paramedian branch of basilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body: Medial lemniscus

11/07/11

MUN FP Academic Half Day

65

CONTRALATERAL (medial syndromes)

Medial medullary syndrome (occlusion of vertebral artery or of branch of vertebral or lower basilar artery) Paralysis of arm and leg, sparing face; impaired tactile and proprioceptive sense over half the body: Contralateral pyramidal tract and medial lemniscus

11/07/11

MUN FP Academic Half Day

66

CONTRALATERAL (Lateral syndromes)

Lateral midbrain syndrome (syndrome of small penetrating arteries arising from posterior cerebral artery) Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

11/07/11

MUN FP Academic Half Day

67

CONTRALATERAL (Lateral syndromes)

Lateral superior pontine syndrome (syndrome of superior Cerebellar artery) Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than arm (there is a tendency to incongruity of pain and touch deficits): Medial lemniscus (lateral portion)
MUN FP Academic Half Day 68

11/07/11

CONTRALATERAL (Lateral syndromes)

Lateral midpontine syndrome (short circumferential artery) Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

69

CONTRALATERAL (Lateral syndromes)

Lateral inferior pontine syndrome (occlusion of anterior inferior Cerebellar artery) Impaired pain and thermal sense over half the body (may include face): Spinothalamic tract

11/07/11

MUN FP Academic Half Day

70

CONTRALATERAL (Lateral syndromes)

Lateral medullary syndrome (occlusion of any of five vessels may be responsiblevertebral, posterior inferior Cerebellar, superior, middle, or inferior lateral medullary arteries) Impaired pain and thermal sense over half the body, sometimes face: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

71

Lateral midpontine syndrome: Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract Lateral inferior pontine syndrome :Impaired pain and thermal sense over half the body (may include face): Spinothalamic tract Lateral medullary syndrome : Impaired pain and thermal sense over half the body, sometimes face: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

72

11/07/11

MUN FP Academic Half Day

73

11/07/11

MUN FP Academic Half Day

74

11/07/11

MUN FP Academic Half Day

75

Medial midbrain syndrome

(paramedian branches of upper basilar and proximal posterior cerebral arteries) Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers

11/07/11

MUN FP Academic Half Day

76

11/07/11

MUN FP Academic Half Day

77

11/07/11

MUN FP Academic Half Day

78

11/07/11

MUN FP Academic Half Day

79

11/07/11

MUN FP Academic Half Day

80

Lacunar infarcts
Lacunar infarcts are small infarcts in the deeper parts of the brain (basal ganglia, thalamus, white matter) and in the brain stem. They are responsible for about 20 percent of all strokes.

11/07/11

MUN FP Academic Half Day

81

Lacunar infarcts
Other names given to this pathology are Small artery arteriosclerosis", Hyaline atreriolosclerosis", Lipohyalinosis".

11/07/11

MUN FP Academic Half Day

82

Lacunar infarcts are caused by small vessel disease.

This nonspecific term refers to a vascular lesion seen primarily in hypertension and diabetes but occurring also in old age.

Other names given to this pathology are "small artery arteriosclerosis", "hyaline atreriolosclerosis", and "lipohyalinosis". This change affects small penetrating arteries and arterioles that originate from the base of the brain and supply the basal ganglia, thalamus, deep white matter, and the brainstem.

11/07/11

MUN FP Academic Half Day

83

Lacunar infarcts

They are caused by occlusion of deep penetrating branches of major cerebral arteries and are particularly common in hypertension and diabetes, which are associated with severe atherosclerosis of small vessels and small vessel disease A small lacunar infarct (e.g., one involving the internal capsule) can cause as severe a neurological deficit as can a much larger hemispheric infarct but without the lifethreatening cerebral edema that is seen in the latter.

11/07/11

MUN FP Academic Half Day

84

Embolic occlusion

Artery-to-artery
Carotid bifurcation Aortic arch Arterial dissection

11/07/11

MUN FP Academic Half Day

85

Cardioembolic
Atrial fibrillation Mural thrombus Myocardial infarction Dilated cardiomyopathy Valvular lesions Mitral stenosis Mechanical valve Bacterial endocarditis Paradoxical embolus Atrial septal defect Patent foramen ovale Atrial septal aneurysm Spontaneous echo contrast

11/07/11

MUN FP Academic Half Day

86

Hypercoagulable disorders

Protein C deficiency Protein S deficiency Antithrombin III deficiency Antiphospholipid syndrome Factor V Leiden mutationa Prothrombin G20210 mutationa Systemic malignancy Sickle cell anemia -Thalassemia Polycythemia vera Systemic lupus erythematosus Homocysteinemia Thrombotic thrombocytopenic purpura

11/07/11

MUN FP Academic Half Day

87

Hypercoaguable disorders

Venous sinous thrombosisb Fibromuscular dysplasia Vasculitis Systemic vasculitis (PAN, Wegener's, Takayasu's, giant cell arteritis) Primary CNS vasculitis Meningitis (syphilis, tuberculosis, fungal, bacterial, zoster)

Disseminated intravascular coagulation Dysproteinemias Nephrotic syndrome Inflammatory bowel disease Oral contraceptives

11/07/11

MUN FP Academic Half Day

88

Cardiogenic

Cardiogenic
Mitral valve calcification Atrial myxoma Intracardiac tumor Marantic endocarditis Libman-Sacks endocarditis

Subarachnoid hemorrhage vasospasm Drugs: cocaine, amphetamine Moyamoya disease Eclampsia

11/07/11

MUN FP Academic Half Day

89

Medial Medullary syndrome


Occlusion of vertebral artery or of branch of vertebral or lower basilar artery On side of lesion Paralysis with atrophy of half the tongue: Ipsilateral twelfth nerve On side opposite lesion Paralysis of arm and leg, sparing face; impaired tactile and proprioceptive sense over half the body: Contra lateral pyramidal tract and medial lemniscus

11/07/11

MUN FP Academic Half Day

90

Lateral Medullary syndrome


Occlusion of any of five vessels may be responsiblevertebral, posterior inferior Cerebellar, superior, middle, or inferior Lateral Medullary arteries On side of lesion Pain, numbness, impaired sensation over half the face: Descending tract and nucleus fifth nerve Ataxia of limbs, falling to side of lesion: Uncertain Restiform body, Cerebellar hemisphere, Cerebellar fibers, Spinocerebellar tract (?) Nystagmus, diplopia, oscillopsia, vertigo, nausea, vomiting: Vestibular nucleus Horner's syndrome (miosis, ptosis, decreased sweating): Descending sympathetic tract

11/07/11

MUN FP Academic Half Day

91

Lateral Medullary syndrome

Dysphagia, hoarseness, paralysis of palate, paralysis of vocal cord, diminished gag reflex: Issuing fibers ninth and tenth nerves Loss of taste: Nucleus and Tractus Solitarius Numbness of ipsilateral arm, trunk, or leg: Cuneate and Gracile nuclei Weakness of lower face: Genuflected upper motor neuron fibers to ipsilateral facial nucleus On side opposite lesion Impaired pain and thermal sense over half the body, sometimes face: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

92

Basilar artery syndrome

The syndrome of the lone vertebral artery is equivalent: A combination of the various brainstem syndromes plus those arising in the posterior cerebral artery distribution. Bilateral long tract signs (sensory and motor; Cerebellar and peripheral cranial nerve abnormalities): Bilateral long tract; Cerebellar and peripheral cranial nerves Paralysis or weakness of all extremities, plus all bulbar musculature: Corticobulbar and corticospinal tracts bilaterally
MUN FP Academic Half Day 93

11/07/11

Medial inferior pontine syndrome


Occlusion of Para median branch of basilar artery On side of lesion Paralysis of conjugate gaze to side of lesion (preservation of convergence): Center for conjugate lateral gaze Nystagmus: Vestibular nucleus Ataxia of limbs and gait: Likely Middle Cerebellar Peduncle Diplopia on lateral gaze: Abducens nerve

11/07/11

MUN FP Academic Half Day

94

Medial inferior pontine syndrome


On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body: Medial lemniscus

11/07/11

MUN FP Academic Half Day

95

Lateral inferior pontine syndrome


Lateral inferior pontine syndrome (occlusion of anterior inferior cerebellar artery) On side of lesion Horizontal and vertical nystagmus, vertigo, nausea, vomiting, oscillopia: Vestibular nerve or nucleus Facial paralysis: Seventh nerve Paralysis of conjugate gaze to side of lesion: Center for conjugate lateral gaze Deafness, tinnitus: Auditory nerve or cochlear nucleus Ataxia: Middle cerebellar peduncle and cerebellar hemisphere Impaired sensation over face: Descending tract and nucleus fifth nerve

11/07/11

MUN FP Academic Half Day

96

Lateral inferior pontine syndrome


On side opposite lesion Impaired pain and thermal sense over half the body (may include face): Spinothalamic tract

11/07/11

MUN FP Academic Half Day

97

Medial mid pontine syndrome


Medial midpontine syndrome (paramedian branch of midbasilar artery) On side of lesion Ataxia of limbs and gait (more prominent in bilateral involvement): Pontine nuclei On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus

11/07/11

MUN FP Academic Half Day

98

Lateral mid pontine syndrome


Lateral mid pontine syndrome (short circumferential artery) On side of lesion Ataxia of limbs: Middle cerebellar peduncle Paralysis of muscles of mastication: Motor fibers or nucleus of fifth nerve Impaired sensation over side of face: Sensory fibers or nucleus of fifth nerve On side opposite lesion Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

99

Medial superior pontine syndrome

Medial superior pontine syndrome (paramedian branches of upper basilar artery)

On side of lesion

On side opposite lesion


Cerebellar ataxia (probably): Superior and/or middle cerebellar peduncle Internuclear ophthalmoplegia: Medial longitudinal fasciculus Myoclonic syndrome, palate, pharynx, vocal cords, respiratory apparatus, face, oculomotor apparatus, etc.: Localization uncertaincentral tegmental bundle, dentate projection, inferior olivary nucleus Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected: Medial lemniscus

11/07/11

MUN FP Academic Half Day

100

Lateral superior pontine syndrome

Lateral superior pontine syndrome (syndrome of superior cerebellar artery)

On side of lesion

Ataxia of limbs and gait, falling to side of lesion: Middle and superior cerebellar peduncles, superior surface of cerebellum, dentate nucleus Dizziness, nausea, vomiting; horizontal nystagmus: Vestibular nucleus Paresis of conjugate gaze (ipsilateral): Pontine contralateral gaze Skew deviation: Uncertain Miosis, ptosis, decreased sweating over face (Horner's syndrome): Descending sympathetic fibers Tremor: Localization unclearDentate nucleus, superior cerebellar peduncle

11/07/11

MUN FP Academic Half Day

101

Medial midbrain syndrome

Medial midbrain syndrome (paramedian branches of upper basilar and proximal posterior cerebral arteries)

On side of lesion Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract descending in crus cerebri

11/07/11

MUN FP Academic Half Day

102

Lateral midbrain syndrome

Lateral midbrain syndrome (syndrome of small penetrating arteries arising from posterior cerebral artery)

On side of lesion Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers and/or third nerve nucleus On side opposite lesion Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

11/07/11

MUN FP Academic Half Day

103

Lateral superior pontine syndrome

On side opposite lesion


Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than arm (there is a tendency to incongruity of pain and touch deficits): Medial lemniscus (lateral portion)

11/07/11

MUN FP Academic Half Day

104

Intravenous Recombinant Tissue Plasminogen Activator


Indication

Clinical diagnosis of stroke Onset of symptoms to time of drug administration 3 h CT scan showing no hemorrhage or edema of > of the MCA territory Age 18 years Consent by patient or surrogate

11/07/11

MUN FP Academic Half Day

105

Contraindication

Sustained BP >185/110 despite treatment Platelets <100,000; HCT <25%; glucose <50 or >400 mg/dL Use of heparin within 48 h and prolonged PTT, or elevated INR Rapidly improving symptoms Prior stroke or head injury within 3 months; prior intracranial hemorrhage Major surgery in preceding 14 days Minor stroke symptoms Gastrointestinal bleeding in preceding 21 days Recent myocardial infarction Coma or stupor

11/07/11

MUN FP Academic Half Day

106

11/07/11

MUN FP Academic Half Day

107

11/07/11

MUN FP Academic Half Day

108

Medial brain stem syndromes


1. Medial midbrain syndrome paramedian branches of upper basilar and proximal posterior cerebral arteries 3. Medial superior pontine syndrome Paramedian branches of upper basilar artery 4. Medial midpontine syndrome Paramedian branch of midbasilar artery 5. Medial inferior pontine syndrome Occlusion of paramedian branch of basilar artery 9. Medial Medullary syndrome Occlusion of vertebral artery or of branch of vertebral or lower basilar artery

11/07/11

MUN FP Academic Half Day

109

Lateral brain stem syndromes


2. Lateral midbrain syndrome Syndrome of small penetrating arteries arising from posterior cerebral artery 6. Lateral superior pontine syndrome Syndrome of superior Cerebellar artery 7. Lateral midpontine syndrome Short circumferential artery 8. Lateral inferior pontine syndrome Occlusion of anterior inferior Cerebellar artery Lateral medullary syndrome: Occlusion of any of five vessels may be responsible vertebral, posterior inferior Cerebellar, superior, middle, or inferior lateral Medullary arteries

11/07/11

MUN FP Academic Half Day

110

Medial brain stem syndromes


Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract descending in crus cerebri Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected Medial lemniscus Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body: Medial lemniscus Paralysis of arm and leg, sparing face; impaired tactile and proprioceptive sense over half the body: Contra lateral pyramidal tract and medial lemniscus

11/07/11

MUN FP Academic Half Day

111

Lateral brain stem syndromes


Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than arm (there is a tendency to incongruity of pain and touch deficits): Medial lemniscus (lateral portion) Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract Impaired pain and thermal sense over half the body (may include face): Spinothalamic tract Impaired pain and thermal sense over half the body sometimes face: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

112

Lateral Medullary syndrome


(occlusion of any of five vessels may be responsiblevertebral, posterior inferior Cerebellar, superior, middle, or inferior lateral Medullary arteries) On side of lesion 1. Pain, numbness, impaired sensation over half the face: Descending tract and nucleus fifth nerve 2. Ataxia of limbs, falling to side of lesion: Uncertain Restiform body, Cerebellar hemisphere, Cerebellar fibers, spino Cerebellar tract (?) 3. Nystagmus, diplopia, oscillopsia, vertigo, nausea, vomiting: Vestibular nucleus 4. Horner's syndrome (miosis, ptosis, decreased sweating): Descending sympathetic tract 5. Dysphagia, hoarseness, paralysis of palate, paralysis of vocal cord, diminished gag reflex: Issuing fibers ninth and tenth nerves 6. Loss of taste: Nucleus and tractus solitarius 7. Numbness of ipsilateral arm, trunk, or leg: Cuneate and gracile nuclei 8. Weakness of lower face: Genuflected upper motor neuron fibers to ipsilateral facial nucleus

11/07/11

MUN FP Academic Half Day

113

Lateral midbrain syndrome


syndrome of small penetrating arteries arising from posterior cerebral artery On side of lesion Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers and/or third nerve nucleus On side opposite lesion Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

11/07/11

MUN FP Academic Half Day

114

Lateral superior pontine syndrome (syndrome of superior Cerebellar artery)


On side of lesion Ataxia of limbs and gait, falling to side of lesion: Middle and superior Cerebellar peduncles, superior surface of cerebellum, dentate nucleus Dizziness, nausea, vomiting; horizontal Nystagmus: Vestibular nucleus Paresis of conjugate gaze (ipsilateral): Pontine contra lateral gaze 4. Skew deviation: Uncertain 5. Miosis, ptosis, decreased sweating over face (Horner's syndrome): Descending sympathetic fibers 6. Tremor: Localization unclear Dentate nucleus, superior Cerebellar peduncle On side opposite lesion Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than arm (there is a tendency to incongruity of pain and touch deficits): Medial lemniscus (lateral portion)

11/07/11

MUN FP Academic Half Day

115

Lateral midpontine syndrome Short circumferential artery


On side of lesion 1. Ataxia of limbs: Middle Cerebellar peduncle 2. Paralysis of muscles of mastication: Motor fibers or nucleus of fifth nerve 3. Impaired sensation over side of face: Sensory fibers or nucleus of fifth nerve On side opposite lesion Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract
MUN FP Academic Half Day 116

11/07/11

Lateral inferior pontine syndrome occlusion of anterior inferior Cerebellar artery


On side of lesion 1.Horizontal and vertical Nystagmus, vertigo, nausea, vomiting, oscillopsia: Vestibular nerve or nucleus 2.Facial paralysis: Seventh nerve Paralysis of conjugate gaze to side of lesion: Center for conjugate lateral gaze 3.Deafness, tinnitus: Auditory nerve or cochlear nucleus 4.Ataxia: Middle Cerebellar peduncle and Cerebellar hemisphere 5.Impaired sensation over face: Descending tract and nucleus fifth nerve On side opposite lesion Impaired pain and thermal sense over half the body (may include face): Spinothalamic tract

11/07/11

MUN FP Academic Half Day

117

Medial Medullary syndrome Occlusion of vertebral artery or of branch of vertebral or lower basilar artery

On side of lesion Paralysis with atrophy of half the tongue: Ipsilateral twelfth nerve On side opposite lesion Paralysis of arm and leg, sparing face; impaired tactile and proprioceptive sense over half the body: Contra lateral pyramidal tract and medial lemniscus

11/07/11

MUN FP Academic Half Day

118

Medial midbrain syndrome paramedian branches of upper basilar and proximal posterior cerebral arteries

On side of lesion Eye "down and out" secondary to unopposed action of fourth and sixth cranial nerves, with dilated and unresponsive pupil: Third nerve fibers On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract descending in crus cerebri
MUN FP Academic Half Day 119

11/07/11

Medial superior pontine syndrome (paramedian branches of upper basilar artery)

On side of lesion 1. Cerebellar ataxia (probably): Superior and/or middle Cerebellar peduncle 2. Internuclear ophthalmoplegia: Medial longitudinal fasciculus 3. Myoclonic syndrome, palate, pharynx, vocal cords, respiratory apparatus, face, oculomotor apparatus, etc.: Localization uncertain central tegmental bundle, dentate projection, inferior olivary nucleus On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected: Medial lemniscus

11/07/11

MUN FP Academic Half Day

120

Medial midpontine syndrome Paramedian branch of midbasilar artery

On side of lesion Ataxia of limbs and gait (more prominent in bilateral involvement): Pontine nuclei On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus
MUN FP Academic Half Day 121

11/07/11

Medial inferior pontine syndrome occlusion of paramedian branch of basilar artery


On side of lesion 1.Paralysis of conjugate gaze to side of lesion (preservation of convergence): Center for conjugate lateral gaze 2.Nystagmus: Vestibular nucleus 3.Ataxia of limbs and gait: Likely middle Cerebellar peduncle 4.Diplopia on lateral gaze: Abducens nerve On side opposite lesion Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body: Medial lemniscus

11/07/11

MUN FP Academic Half Day

122

On side opposite lesion


1. Medial midbrain syndrome paramedian branches of upper basilar and proximal posterior cerebral arteries Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract descending in crus cerebri 2. Lateral midbrain syndrome Syndrome of small penetrating arteries arising from posterior cerebral artery Hemiataxia, hyperkinesias, tremor: Red nucleus, dentatorubrothalamic pathway

11/07/11

MUN FP Academic Half Day

123

Medial pontine syndromes


3. Medial superior pontine syndrome (Paramedian branches of upper basilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Rarely touch, vibration, and position are affected Medial lemniscus 4. Medial midpontine syndrome Paramedian branch of midbasilar artery Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract Variable impaired touch and proprioception when lesion extends posteriorly: Medial lemniscus 5. Medial inferior pontine syndrome (Occlusion of paramedian branch of basilar artery) Paralysis of face, arm, and leg: Corticobulbar and corticospinal tract in lower Pons Impaired tactile and proprioceptive sense over half of the body: Medial lemniscus

11/07/11

MUN FP Academic Half Day

124

Lateral pontine syndromes


6. Lateral superior pontine syndrome (Syndrome of superior Cerebellar artery) Impaired pain and thermal sense on face, limbs, and trunk: Spinothalamic tract Impaired touch, vibration, and position sense, more in leg than arm (there is a tendency to incongruity of pain and touch deficits): Medial lemniscus (lateral portion) 7. Lateral midpontine syndrome Short circumferential artery Impaired pain and thermal sense on limbs and trunk: Spinothalamic tract 8. Lateral inferior pontine syndrome (occlusion of anterior inferior Cerebellar artery) Impaired pain and thermal sense over half the body (may include face): Spinothalamic tract

11/07/11

MUN FP Academic Half Day

125

Contra lateral

9. Medial Medullary syndrome Occlusion of vertebral artery or of branch of vertebral or lower basilar artery Paralysis of arm and leg, sparing face; impaired tactile and proprioceptive sense over half the body: Contra lateral pyramidal tract and medial lemniscus 10. Lateral medullary syndrome: (Occlusion of any of five vessels may be responsible vertebral, posterior inferior Cerebellar, superior, middle, or inferior lateral Medullary arteries) Impaired pain and thermal sense over half the body sometimes face: Spinothalamic tract

11/07/11

MUN FP Academic Half Day

126

BRAIN-STEM SYNDROMES

WEBER (ANTERIOR CEREBRAL PEDUNCLE MIDBRAIN) IL3+CL7UMN+CLHP CLAUDE; CEREBRAL PEDUNCLE INVOLVING RED NUCLEUS IL3 + CL CEREBELLAR SIGNS

11/07/11

MUN FP Academic Half Day

127

PARINAUD;

DORSAL MB/ TECTUM VERTICAL GAZE PALSY+ CONVERGENCE DISORDERS + CONVERGENCE RETRACTION+ NYSTAGMUS+ PUPILLARY & LID DISORDERS

11/07/11

MUN FP Academic Half Day

128

MILLARD-GUBLAR;

PONTO-MEDULLARY Jn. IL6+IL7LMN CLHP

11/07/11

MUN FP Academic Half Day

129

WALLENBERG;LATERAL MEDULLARY SYNDROME;

IL5,7,9,10,11+IL HONER+IL CEREBELLAR+ CL SPINOTHALAMIC VESTIBULAR DISTURBANCE.

11/07/11

MUN FP Academic Half Day

130

Vernet 9,10,11

Jugular foramen (inside the skull) Metastases, neurinoma, meningioma, Epidermoid & carotid body tumor.

11/07/11

MUN FP Academic Half Day

131

Collet Sicard 9,10,11,12

Jugular foramen (out side the skull near foramen lacerum) Metastases, neurinoma, meningioma, Epidermoid & carotid body tumor.

11/07/11

MUN FP Academic Half Day

132

Villaret 9,10,11,12 & Horner's

Posterior retropharyngeal space near carotid artery Carotid dissection, Metastases, neurinoma, meningioma, Epidermoid & carotid body tumor.

11/07/11

MUN FP Academic Half Day

133

Isolated 12th

Skull base (hypoglossal canal) Metastases, neurinoma, meningioma, Epidermoid.

11/07/11

MUN FP Academic Half Day

134

11/07/11

MUN FP Academic Half Day

135

11/07/11

MUN FP Academic Half Day

136

11/07/11

MUN FP Academic Half Day

137

11/07/11

MUN FP Academic Half Day

138

11/07/11

MUN FP Academic Half Day

139

11/07/11

MUN FP Academic Half Day

140

11/07/11

MUN FP Academic Half Day

141

11/07/11

MUN FP Academic Half Day

142

11/07/11

MUN FP Academic Half Day

143

Caused by virus. Less severe Resolves without specific treatment within a week or two Also called as aseptic meningitis Eg : Enteroviruses (family of viruses)

Caused by bacteria Quite severe and may result in a) brain damage b) hearing loss c) learning disability It would also causes death!

For bacterial meningitis, it is also important to know which type of bacteria is causing the meningitis because antibiotics can prevent some types from 11/07/11 spreading and infecting other people. MUN FP Academic Half Day

144

11/07/11

MUN FP Academic Half Day

145

11/07/11

MUN FP Academic Half Day

146

11/07/11

MUN FP Academic Half Day

147

Haemophilus Influenzae type b (Hib)

Meningococcus

Pneumococcus

11/07/11

MUN FP Academic Half Day

148

Meningococcus

common organisms that cause meningitis in children. caused by bacteria called Neisseria meningitidis. There are several strains of Neisseria meningitidis. Strain B causes about 75 percent of the meningococcal cases and has the highest fatality rate.

11/07/11

MUN FP Academic Half Day

149

Haemophilus Influenzae type B (Hib)

is caused by haemophilus bacteria. It was once the most common form of bacterial meningitis, one of the deadliest childhood diseases.

11/07/11

MUN FP Academic Half Day

150

Pneumococcus

is caused by pneumococcus bacteria, which also cause several diseases of the respiratory system, including pneumonia. It has a fatality rate of about 20 percent. It also results in a higher incidence of brain damage than other forms of the disease.

11/07/11

MUN FP Academic Half Day

151

Symptoms

Symptoms of meningitis can come on very quickly or take a couple of days to appear. Most cases of meningitis occur in the first 5 years of life, with the peak life incidence between 3 and 5 months of age.
11/07/11 MUN FP Academic Half Day 152

1. 2. 3. 4. 5. 6. 7.

Older people: Lethargy Recurring headaches Difficulty in concentration Short-term memory loss Clumsiness Balance problems Depression

11/07/11

MUN FP Academic Half Day

153

Serious complications

Other serious complications can include: Brain damage Epilepsy Changes in eye sight

1.

1.

2.

11/07/11

MUN FP Academic Half Day

154

SUMMARY

Meningitis is an inflammation of the protective membrane lining the brain and spinal cord caused most often by a viral or bacterial infection that crosses the body's blood-brain barrier. Meningitis is diagnosed by a lumbar puncture , in which a small amount of fluid is collected from the spinal column. There are two main types of meningitis: bacterial and viral. Bacterial meningitis is less common, but more serious.
MUN FP Academic Half Day 155

11/07/11

SUMMARY

Bacterial meningitis is treated with antibiotics and the majority of patients make a full recovery. Viral meningitis usually requires no treatment beyond painkillers. Most patients make a full recovery from meningitis. A small number of infected people end up with hearing or vision loss or brain damage. Vaccinations against some forms of meningitis are available. They are recommended for children under age 5, people in close contact with someone who has developed meningitis, college students, and people traveling to certain overseas destinations.

11/07/11

MUN FP Academic Half Day

156

Brain Abscess Definition

A focal, intracerebral infection that begins as a localized area of cerebritis ->a collection of pus surrounded by a wellvascularized capsule

~Clin Infect Dis. 1997 Oct;25(4):763-79

11/07/11

MUN FP Academic Half Day

157

Common Sources of Brain Abscess


1.

2.

3.

4.

Direct or indirect infection from paranasal sinuses, middle ear, and teeth (via valveless emissary veins to cavernous sinus) Penetrating brain injury (low incidence) Metastatic seeding from distant extracranial sources Cryptic (20%~30%) : PFO?
MUN FP Academic Half Day 158

11/07/11

11/07/11

Clin Microbiol Infect 2003;9;803-809 MUN FP Academic Half Day

159

11/07/11

Clin Microbiol Infect 2003;9;803-809 MUN FP Academic Half Day

160

PREDISPOSING FACTORS

IVDA (2.5%) Congenital heart disease (6.1%) HIV infection (1.2%) Immunosuppression (3.7%) Diabetes mellitus (3.1%)

11/07/11

MUN FP Academic Half Day

161

Stages
1. Early cerebritis stage (D1-3):focal area of inflammation and edema 2. Late cerebritis stage (D4-9):development of a necrotic central focus 3. Early capsule stage (D10-14):ring-enhancing capsule of well-vascularized tissue with early appearance of peripheral fibrosis 4. Late capsule stage (>D14):host defenses lead to a well-formed capsule ~Clin Infect Dis. 1997 Oct;25(4):763-79

11/07/11

MUN FP Academic Half Day

162

IMAGING STUDIES
1.

Contrasted CT focal hypodensity->enhances after iv contrast->ring-enhanced lesion Frequently located in watershed areas, regular thin-walled capsule with peripheral enhancement Brain tumor: irregular border & diffuse enhancement
MUN FP Academic Half Day 163

11/07/11

IMAGING STUDIES
2. MRI T1: hypointense with ring-enhancement T2: hyperintense central area of pus surrounded by a well-defined hypointense capsule & edema-> surgery 3. Radionuclide scan D/D brain abscess from tumor

11/07/11

MUN FP Academic Half Day

164

11/07/11

MUN FP Academic Half Day

165

Function Function

Cerebellum Cerebellum

Maintenance of Equilibrium - balance, posture, eye movement Coordination of half-automatic movement of walking and posture maintenace - posture, gait Adjustment of Muscle Tone Motor Leaning Motor Skills Cognitive Function
11/07/11 MUN FP Academic Half Day

Motor Skill

Pablo Casals Pablo Casals

11/07/11

MUN FP Academic Half Day

167

Syndromes Syndromes

Cerebellum Cerebellum

Clinical Clinical

Ataxia: incoordination of movement - decomposition of movement - dysmetria, past-pointing - dysdiadochokinesia - rebound phenomenon of Holmes - gait ataxia, truncal ataxia, titubation Intention Tremor Hypotonia, Nystagmus Archicerebellar Lesion: medulloblastoma Paleocerebellar Lesion: gait disturbance Neocerebellar Lesion: hypotonia, ataxia, tremor
11/07/11 MUN FP Academic Half Day

Cerebellar Ataxia
Ataxic gait and position: Left cerebellar tumor a. Sways to the right in standing position b. Steady on the right leg c. Unsteady on the left leg d. ataxic gait

11/07/11

MUN FP Academic Half Day

169

Cerebellar Medulloblastoma
Cerebellar tumors on vermis - Truncal Ataxia - Frequent Falling The child in this picture: - would not try to stand unsupported - would not let go of the bed rail if she was stood on the floor.
11/07/11 MUN FP Academic Half Day 170

Balance

11/07/11

MUN FP Academic Half Day

171

What is Multiple Sclerosis?


It is an Auto Immune Disease which is when the body starts to destroy itself. It is a life-long disease with no cure. In MS, the body attacks and destroys the fatty tissue called myelin that insulates an axon/nerve, and is called demyelination.

11/07/11

MUN FP Academic Half Day

172

What is Multiple Sclerosis?

Multiple Sclerosis (MS) is an chronic inflammatory demyelinating disease of the brain and spinal cord.

11/07/11

MUN FP Academic Half Day

173

The Human Nervous System

Areas affected by MS

Brain Spinal cord Optic nerves

11/07/11

(http://web.lemoyne.edu/~hevern/psy340/lectures/psy340.04.2.ns.structure.html) MUN FP Academic Half Day

174

Initial Presentation of MS
Optic nerve inflammation Poor balance (ataxia) Dizziness (vertigo) Weakness Double visions (diplopia) Bladder, bowel dysfunction Pain Sensory loss
11/07/11 MUN FP Academic Half Day

Incidence (%) 1429 218 29 1040 818 014 2140 1339


175

Other Common Symptoms of MS


Fatigue Spasticity Sexual

dysfunction Cognitive impairment


Generally

occurs later in the

disease

11/07/11

MUN FP Academic Half Day

176

Multiple Sclerosis Clinical Subtypes


Relapsing-remitting Secondary-progressive

Disability

Time Primary-progressive

Disability
Time Progressive-relapsing Time

Disability

Disability
Time
MUN FP Academic Half Day

Lublin FD et al. Neurology. 1996;46:907-911.

11/07/11

177

How Is MS Diagnosed?

At least two episodes of symptoms


Occur

at different points in time Result from involvement of different areas of the central nervous system

Absence of other treatable causes for the symptoms Results of neurological testing

11/07/11

MUN FP Academic Half Day

178

Other Potential Causes of MS-like Symptoms


Lyme disease Lupus Migraine Non-recurrent inflammatory process Encephalitis Stroke Tumor of the brain or spinal cord

11/07/11

MUN FP Academic Half Day

179

Brain Atrophy (Shrinkage) in Untreated MS

Images acquired over the course of 7 years from a single person with untreated MS
11/07/11 MUN FP Academic Half Day 180

Brain Atrophy (Shrinkage) in Untreated MS

11/07/11

MUN FP Academic Half Day

181

Treatment of New MS Exacerbations

Drug therapy
Corticosteroids Intravenous

immunoglobulin Plasma exchange

Physical therapy

11/07/11

MUN FP Academic Half Day

182

Glatiramer acetate

11/07/11

MUN FP Academic Half Day

183

Prevention of Future Attacks and Disease Progression

Immune modulating drugs


Beta-Interferon Glatiramer

acetate Humanized monoclonal antibodies

Immunosuppressant drugs
Anti-cancer

agents

Combination therapies

11/07/11

MUN FP Academic Half Day

184

Symptom Management Examples


Pain control Management of impaired bladder and bowel function Anti-spasmodic drugs Treatment of fatigue Splinting for contractures Counseling

11/07/11

MUN FP Academic Half Day

185

MS Therapies: What Lies Ahead?


Neural protection Regenerative therapies Cell replacement (stem cells) Dietary approaches (vitamin D)

11/07/11

MUN FP Academic Half Day

186

Multiple Sclerosis

If damage is severe it can also destroy the nerve/axon itself. MS affects the central nervous system and inflames the white matter in the brain which creates plaques. White matter is below the top layer of our brain and spinal cord. Plaques block a signal from being passed from the body to the spinal cord and brain. Currently in the US, 250,000-300,000 people have been diagnosed with MS and there are 200 new cases diagnosed every week.

11/07/11

MUN FP Academic Half Day

187

Diagnostic categories of MS

The phrase multiple abnormalities in space and time sums up what a physician needs to find a diagnosis of MS (OConnor 32). There are three categories of MS; Definite, Probable, and Possible MS.

11/07/11

MUN FP Academic Half Day

188

Possible MS:
There is no documented signs of MS and more than one lesion. There is also a history of one relapse-remitting symptoms.

11/07/11

MUN FP Academic Half Day

189

Probable MS:
Here the signs are not previously documented and there is one current sign of MS. There is more than one site of lesions, they have a good recovery and have a history of relapse-remitting symptoms.

11/07/11

MUN FP Academic Half Day

190

Definite MS:

Consistent course (relapse-remitting course with at least 2 bouts separated by at least 1 month or slow or stepwise progressive course for at least 6 months) of documented neurological signs of lesions in more than one site of brain or spinal cord white matter ( Hope 7). The age of onset is between 10 and 50 years of age.

11/07/11

MUN FP Academic Half Day

191

Symptoms of MS

Fatigue Depression Memory change Pain Spasticity Vertigo Tremor Double Vision/Vision Loss

Weakness Dizziness/Unsteadines s Numbness/Tingling Ataxia Euphoria Speech disturbance Bladder/Bowel/Sexual dysfunction

11/07/11

MUN FP Academic Half Day

192

Medications used for MS


Spasticity- Baclofen, Tizanidine, Diazepam, Dantrolene Optic Neuritis- Methlyprednisolone, Oral steroids Fatigue- Antidepressant, Amantadine Pain- Codeine, Aspirin Sexual Dysfunction- Viagra, Pravatine Tremor- Isoniazid, Primidone, Propranolol Disease-Modifying Drugs- Interferon beta 1a and
1b, and Glatiramer acetate

11/07/11

MUN FP Academic Half Day

193

Interferon Beta 1b (Betaseron):


Is slightly different from our own interferon. This medication does the same thing as beta 1a, but is injected just under the skin every two days. Side effects include irritation, bruising, and redness at the site of injection and the flu like symptoms. This is also given to people who have definite progressive MS.

11/07/11

MUN FP Academic Half Day

194

Disease-Modifying Drugs

(cont)

Glatiramer Acetate ( Copaxone): is a small fragment of a protein that resembles a protein in myelin ( OConnor 106). It decrease the reoccurrence of relapse. It is injected just under the skin every day. There is no flu like symptoms but occasional redness may occur at the injection site. A few amount of people do experience brief shortness of breathe.

In summary all three of these drugs decrease relapses by 33%, have manageable side effect, are injected, stabilize the disease, and tend to be costly.

11/07/11

MUN FP Academic Half Day

195

Parkinson Disease

Neurological disease affecting over four million patients worldwide, over 1.5 million people in the U.S.. While it can affect individuals at any age, it is most common in the elderly. The average age of onset is 55 years, although approximately 10 percent of cases affect those under age 40.

11/07/11

MUN FP Academic Half Day

196

11/07/11

MUN FP Academic Half Day

197

Clinical Characteristics

James Parkinson, 1917 ...involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported; with a propensity to bend the trunk forwards, and to pass from a walking to a funning pace, the senses and the intellects uninjured. rhythmic tremor at rest

rigidity with cog-wheel characteristic akinesia


11/07/11 MUN FP Academic Half Day 198

Pathology of Parkinson's
Death of Dopamine neurons in the Substantia Nigra Loss of Dopamine in the Caudate Loss of Inhibition in the Caudate Overactive output (globus pallidus) to the thalamus Thalamus over inhibits the motor cortex Complex basal ganglia-cortical loops
11/07/11 MUN FP Academic Half Day 199

EPIDEMIOLOGY
fifth or sixth decade of life 85% idiopathic prevalence: 3 per 1000 cumulative life-time risk: 1 in 40 approximately 1 million patients
11/07/11

no cure

MUN FP Academic Half Day

200

ETIOLOGY
Genetic Factors
1999 - examined 17,000 twins > 50 years old: no genetic effect < 50 years old: 10 % genetic defect Diet vitamins, antioxidants incidence

Smoking incidence Environment incidence in rural areas dopamine neuron toxins


11/07/11 MUN FP Academic Half Day 201

Pathophysiology of Parkinsons Disease Normal


STRIATUM
PALLIDUM THALAMUS SUBSTANTA NIGRA

MOTOR CORTEX

Pathology
STRIATUM MOTOR CORTEX

PALLIDUM THALAMUS
11/07/11

SUBSTANTA NIGRA MUN FP Academic Half Day

202

STAGES OF PARKINSON'S DISEASE


DOPAMINE (% control) 100 80 ADAPTIVE CAPACITY 60 40 20 DECOMPENSATION 0
11/07/11

COMPENSATION -no symptoms MILD SYMPTOMS MARKED SYMPTOMS


MUN FP Academic Half Day 203

Levodopa therapy
Main treatment is with L-DOPA Precursor for dopamine Sinemet is L-DOPA + carbidopa carbidopa is a peripheral decarboxylase inhibitor - prevents L-DOPA catabolism Main problems: - on/off fluctuations - dyskinesias - eventually doesnt work - peripheral side effects (NE and E) Anticholinergics help as well On-off fluctuations too great with DA agonists
11/07/11 MUN FP Academic Half Day

204

Drugs used to treat Parkinsons Disease

11/07/11

MUN FP Academic Half Day

205

Appears

Later in Life Continuous Progressive Neurological Disease, thereby causing increasing disability of movement no cure

11/07/11

MUN FP Academic Half Day

206

Etiology
Cerebral

atherosclerosis Viral encephalitis Side effects of several antipsychotic drugs (i.e., phenothiazides, butyrophenones, reserpine)

11/07/11

MUN FP Academic Half Day

207

Environmental factors and neurotoxins


Pesticides,

herbicides, industrial chemicals - contain substances that inhibit complex I in the mitochondria

11/07/11

MUN FP Academic Half Day

208

11/07/11

MUN FP Academic Half Day

209

In Terms of Etiology and Clinical Picture, Major Symptoms Involve:

Bradykinesia- Slowness in Initiation and Execution of Voluntary Movements Rigidity - Increase Muscle Tone and Increase Resistance to Movement (Arms and Legs Stiff) Tremor - Usually Tremor at Rest, When Person Sits, Arm Shakes, Tremor Stops When Person Attempts to Grab Something Postural Instability - abnormal fixation of posture (stoop when standing), equilibrium, and righting reflex Gait Disturbance - Shuffling Feet
MUN FP Academic Half Day 210

11/07/11

Usually Other Accompanied Autonomic Deficits Seen Later in Disease Process:


Orthostatic Hypotension Dementia Dystonia Ophthalmoplegia Affective Disorders

11/07/11

MUN FP Academic Half Day

211

Parkinson Disease Neurochemistry

Loss of Dopaminergic (DA) Cells Located in Basal Ganglia; most symptoms do not appear until striata DA levels decline by at least 70-80%.

11/07/11

MUN FP Academic Half Day

212

Imbalance

primarily between the excitatory neurotransmitter Acetylcholine and inhibitory neurotransmitter Dopamine in the Basal Ganglia
DA

ACh
11/07/11 MUN FP Academic Half Day 213

The Dopaminergic Neurons in the Basal Ganglia Are mainly affected Acetylcholine within striatum is a tonically activated neuron It impinges on GABA Neuron by an Excitatory Action GABA Neuron Has an Inhibitory Action on the Substantia Nigra from Substantia Nigra, Has a Dopaminergic Feed Back Loop Back to Striatum Which Gets Loss Giving Signs and Symptoms of Parkinson Disease
MUN FP Academic Half Day 214

11/07/11

Basal Ganglia

The Basal Ganglia Consists of Five Large Subcortical Nuclei That Participate in Control of Movement:
Caudate Putamen Globus

Nucleus

Pallidus Subthalamic Nucleus Substantia Nigra

11/07/11

MUN FP Academic Half Day

215

The balance of the five large Subcortical Nuclei are responsible for smooth motor movements

The primary input is from the Cerebral Cortex, and the output Is directed through the thalamus back to the Prefrontal, Premotor, and Motor Cortex The motor function of the basal ganglia are therefore mediated by the Frontal Cortex Neurotransmitters in Basal Ganglia Include Serotonin, Acetylcholine, GABA, Enkephalin, Substance P, Glutamate, and Dopamine Dopamine from Substantia Nigra decreases release of acetylcholine from striatum.
MUN FP Academic Half Day 216

11/07/11

Drug Therapy
Drug Therapy Against Parkinson Disease Is Aimed at Bringing the Basal Ganglia Back to Balance

Decrease Cholinergic Activity Within Basal Ganglia and this Can Be Done Two Ways: Activating Dopamine receptors in Substantia Nigra feeding back to Cholinergic Cells in the striatum Turn off the Cholinergic Cells, Then Things Are Brought Back to Balance Antagonize Acetylcholine receptors

11/07/11

MUN FP Academic Half Day

217

Agents that Increase Dopamine functions


Increasing the synthesis of dopamine - lDopa Inhibiting the catabolism of dopamine selegiline Stimulating the release of dopamine amphetamine Stimulating the dopamine receptor sites directly - bromocriptine & pramipexole Blocking the uptake and enhancing the release of dopamine - amantadine

11/07/11

MUN FP Academic Half Day

218

Dopamine and Tyrosine Are Not Used for Parkinson Disease Therapy

Dopamine Doesn't Cross the Blood Brain Barrier Huge amount of tyrosine decreases activity of rate limiting enzyme Tyrosine Hydroxylase That normally Converts Tyrosine to dopamine by overwhelming enzyme tyrosine hydroxylase, has a feedback loop that will turn off tyrosine hydroxylase

11/07/11

MUN FP Academic Half Day

219

L Dopa Therapy for Parkinson Disease


Dopamine

Decarboxylase Converts L Dopa to Dopamine That Gets Stored into Secretory Vesicles and Gets Released from Basal Ganglia

11/07/11

MUN FP Academic Half Day

220

Effects of L Dopa on the Symptoms of Parkinson Disease

L Dopa Fairly Effective in Eliminating Most of the Symptoms of Parkinson Disease Bradykinesia and Rigidity Quickly Respond to L Dopa Reduction in Tremor Effect with Continued Therapy L Dopa less Effective in Eliminating Postural Instability and Shuffling Gait Meaning Other Neurotransmitters Are Involved in Parkinson Disease

11/07/11

MUN FP Academic Half Day

221

Long Term Therapy


Behavioral Disturbances in 20 to 25% of Population Trouble in Thinking (Cognitive Effects) L Dopa Can Induce: Psychosis Confusion Hallucination Anxiety Delusion Some Individuals develop Hypomania Which Is Inappropriate Sexual Behavior; "Dirty Old Man", "Flashers"

11/07/11

MUN FP Academic Half Day

222

"On/off" Effect

"On/off" Effect Is like a Light Switch ; Without Warning, All of a Sudden, Person Goes from Full Control to Complete Reversion Back to Bradykinesia, Tremor, Etc. Lasting from 30 Minutes to Several Hours and Then Get Control Again "On/off" Effect Occurs after usually after 2 or more years on L Dopa Related to Denervation Hypersensitivity

11/07/11

MUN FP Academic Half Day

223

Treat by Giving Small Dose Regiments from 16 to 20 Hours "On/off" Effect May Be Due to Composite of Amino Acids That Use Same Dopamine Transportor across Gastric Mucosa causing extremely low levels of L Dopa in CNS thereby causing symptoms of Parkinson Disease to reappear. Changing diet (to low protein), may cause large conc of L Dopa in CNS Giving thus producing an 'off' Effect of Symptoms of Parkinson Disease

11/07/11

MUN FP Academic Half Day

224

Bromocriptine

For Treating Parkinson Disease ; an Ergotamine derivative, acts as a Dopamine Receptor Agonist the Drug Produces Little Response in Patients That Do Not React to Levodopa

11/07/11

MUN FP Academic Half Day

225

Pramipexole
11/07/11 MUN FP Academic Half Day 226

Pramipexole

Pramipexole is a nonergot dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D2 subfamily of dopamine receptors, binding with higher affinity to D3 than to D2 or D4 receptor subtypes. Precise mechanism of action is unknown, although it is believed to be related to its ability to stimulate dopamine receptors in the striatum.

11/07/11

MUN FP Academic Half Day

227

Amantadine

Amantadine for Treating Parkinson Disease Amantadine Effective as in the Treatment of Influenza, however has significant Antiparkinson Action; it appears to Enhance Synthesis, Release, or Reuptake of Dopamine from the Surviving Nigral Neurons

11/07/11

MUN FP Academic Half Day

228

Deprenyl ( Selegiline)

Deprenyl ( Selegiline) for Treating Parkinson Disease Deprenyl Selectively Inhibits Monoamine Oxidase B Which Metabolizes Dopamine, but Does Not Inhibit Monoamine Oxidase a Which Metabolizes Norepinephrine and Serotonin

11/07/11

MUN FP Academic Half Day

229

The Protective Effects of Selegiline


Although the factors responsible for the loss of nigrostriatal dopaminergic neurons in Parkinson's disease are not understood, the findings from neurochemical studies have suggested that the surviving striatal dopamine neurons accelerate the synthesis of dopamine, thus enhancing the formation of H202 according to the following scheme.
11/07/11 MUN FP Academic Half Day 230

Amphetamine for Treating Parkinson Disease

Amphetamine Has Been Used Adjunctively in the Treatment of Some Parkinsonian Patients it Is Thought That, by Releasing Dopamine and Norepinephrine from Storage Granules, Amphetamine Makes Patients More Mobile and More Motivated

11/07/11

MUN FP Academic Half Day

231

Catechol-O-methyltransferase (COMT) inhibitors


Tolcapone (Tasmar) and Entacapone (Comtan) are two well-studied COMT inhibitors. Increases the duration of effect of levodopa dose Can increase peak levels of levodopa Should be taken with carbidopa/levodopa (not effective used alone) Can be most beneficial in treating "wearing off" responses Can reduce carbidopa/levodopa dose by 20-30%

11/07/11

MUN FP Academic Half Day

232

Antimuscarinic Agents for Treating Parkinson Disease

The Antimuscarinic Agents Are Much less Efficacious than Levodopa, and These Drugs Play Only an Adjuvant Role in Antiparkinson Therapy the Actions of Atropine, Scopolamine, Benztropine, Trihexyphenidyl, and Biperiden Are Similar

11/07/11

MUN FP Academic Half Day

233

On the Horizon

A number of potential Parkinson's treatments in research laboratories now show much promise. They include:

Neurotrophic proteins--These appear to protect nerve cells from the premature death that prompts Parkinson's. One hurdle is getting the proteins past the blood-brain barrier. Neuroprotective agents--Researchers are examining naturally occurring enzymes that appear to deactivate "free radicals," chemicals some scientists think may be linked to the damage done to nerve cells in Parkinson's and other neurological disorders.

11/07/11

MUN FP Academic Half Day

234

Spinal Cord Spinal Cord

Tracts Tracts

Ascending Tracts Ascending Tracts


Posterior White Column-Medial Lemniscal Pathway Posterior White Column-Medial Lemniscal Pathway Spinothalamic Tract Spinothalamic Tract Spinoreticular or Spinoreticulothalamic Tract Spinoreticular or Spinoreticulothalamic Tract Spinocerebellar Tract Spinocerebellar Tract Spinomedullothalamic Tract Spinomedullothalamic Tract Cervicothalamic or Spinocervicothalamic Tract Cervicothalamic or Spinocervicothalamic Tract Spino-olivary Tract Spino-olivary Tract Spinotectal Tract Spinotectal Tract
11/07/11 MUN FP Academic Half Day

Spinal Cord Spinal Cord

Descending Tracts Descending Tracts

Descending Tracts from Brain Stem Descending Tracts from Brain Stem
Dorsolateral (Motor) Pathway Dorsolateral (Motor) Pathway Rubrospinal Tract Rubrospinal Tract Ventromedial (Motor) Pathway Ventromedial (Motor) Pathway Tectospinal Tract Tectospinal Tract Vestibulospinal Tract Vestibulospinal Tract MLF (Medial Longitudinal Fasciculus) MLF (Medial Longitudinal Fasciculus) --interstitiospinal tract interstitiospinal tract Sensory Modulation pathways Sensory Modulation pathways Raphespinal & Cerulospinal Pathways Raphespinal & Cerulospinal Pathways Descending Autonomic Pathways Descending Autonomic Pathways
11/07/11 MUN FP Academic Half Day

Upper Motor Neuron (UMN) vs. Lower Motor Neuron (LMN) Syndrome UMN syndrome Type of Paralysis Atrophy Deep Tendon Reflex Pathological Reflex Superficial Reflex Fasciculation and Fibrillation
11/07/11

LMN Syndrome Flaccid Paralysis Severe Atrophy Absent DTR Absent Present Could be Present

Spastic Paresis No (Disuse) Atrophy Increase Positive Babinski Sign Absent Absent

MUN FP Academic Half Day

Spinal Cord Spinal Cord

Syndrome Syndrome

Predominantly Motor Syndromes Poliomyelitis (Infantile Paralysis)


- viral infection of lower motor neuron - LMN syndrome at the level of lesion

Amyotrophic Lateral Sclerosis (ALS)


- combined LMN and UMN lesion - LMN syndrome at the level of lesion - UMN syndrome below the level of lesion - Lou Gehrigs disease
11/07/11 MUN FP Academic Half Day

Spinal Cord Spinal Cord

Syndrome Syndrome

Predominantly Sensory Syndromes Herpes Zoster


- inflammatory reactions of spinal ganglion - severe pain on the dermatomes of affected ganglion

Tabes Dorsalis
- common variety of neurosyphilis - posterior column and spinal posterior root lesion - loss of discriminative touch sensation and conscious proprioception below the level of lesion - posterior column ataxia - lancinating pain (a stabbing or piercing sensation) - loss of deep tendon reflex (DTR)
11/07/11 MUN FP Academic Half Day

Spinal Cord Spinal Cord

Syndrome Syndrome

Sub-Acute Combined Degeneration (Combined System Disease)


Lesion - posterior white column - corticospinal tract (UMN) Symptom - loss of discriminative touch sensation and conscious proprioception below the level of lesion - ipsilateral UMN syndrome below the level of lesion

11/07/11

MUN FP Academic Half Day

Spinal Cord Spinal Cord

Syndrome Syndrome

Syringomyelia, Hematomyelia
Lesion - central canal of spinal cord - gradually extended to peripheral part of the cord Symptom - initial symptom is bilateral loss of pain (compression of anterior white commissure) - variety of symptoms appear according to the lesion extended from central canal
11/07/11 MUN FP Academic Half Day

Spinal Cord Spinal Cord

Syndrome Syndrome

Brown-Sequard syndrome
(spinal cord hemisection)
Major Symptoms 1. ipsilateral UMN syndrome below the level of lesion 2. ipsilateral LMN syndrome at the level of lesion 3. ipsilateral loss of discriminative touch sensation and conscious proprioception below the level of lesion (posterior white column lesion) 4. contralateral loss of pain and temperature sensation below the level of lesion (spinothalamic tract lesion)
11/07/11 MUN FP Academic Half Day

Interferon Beta 1a (Avonex and Rebif):


Is a protein that is a replica of human interferon. It suppress the immune system and helps to maintain the blood-brain barrier. You inject Avonex into the muscle once a week and Rebif is injected under the skin three times a week. This drug is useful to people who have definite progressive MS. One side effect of the drug is a flu like symptom.

11/07/11

MUN FP Academic Half Day

243

Courses of MS

11/07/11

MUN FP Academic Half Day

244

Relapse-remitting MS (RRMS):

Here have an attack, go into complete or partial remission, then have the symptoms return.

11/07/11

MUN FP Academic Half Day

245

Primary-progressive MS (PPMS):

Here continually decline and have no remissions. There may be a temporary relief in symptoms. A few patients have malignant MS which is where they have a quick decline which leaves them severely disabled or even lead to death.

11/07/11

MUN FP Academic Half Day

246

Secondary-progressive MS (SPMS):

This stage of MS starts with RRMS symptoms and continues on to show signs of PPMS.

11/07/11

MUN FP Academic Half Day

247

Progressive-relapsing MS (PRMS):

This is a rare form but here it takes a progressive route made worse by acute attacks. 20% of the people with MS have a benign form. Here they show little progression after the first attack.

11/07/11

MUN FP Academic Half Day

248

CNS EXAMINATION

HIF CRANIAL NERVES MOTOR SYSTEM SENSORY SYSTEM CEREBALLAR SIGNS MENINGEAL SIGNS GAIT

11/07/11

MUN FP Academic Half Day

249

LMN LESION;

WEAKNESS HYPOTONIA AREFLEXIA WASTING DISTRIBUTION OF WASTING / WEAKNESS CONSISTENT WITH LESION IN NERVE SEGMENT, NERVE ROOT & PERIPHERAL NERVE.
MUN FP Academic Half Day 250

11/07/11

UMN LESION

WEAKNESS IN CORTICOSPINAL DISTRIBUTION, SH.AB, HIP.FLEX & DORSIFLEXION FINE & DISTAL MOVEMENTS EPR SPASTICITY HYPERREFLEXIA LITTLE OR NO ATROPHY
MUN FP Academic Half Day 251

11/07/11

EPD / DYSTONIA

PLASTIC OR SPASTIC INCREASE IN MUSCLE TONE ABNORMAL POSTURES INVOLUNTARY MOVEMENTS & TREMORS NORMAL OR INCREASED REFLEXES PLANTAR RESPONSES NORMAL OR EXTENSOR

11/07/11

MUN FP Academic Half Day

252

EPS

BASAL GANGLIA (CLASS), STUCTURES IN THE BRAIN STEM NO DIRECT PATHWAYS FROM BASAL GANGLIA TO THE SPINAL CORD. FIBRES FROM CEREBRAL CORTEX & THALAMUS DENTATORUBRO SPINAL, RETICULO SPINAL, VESTIBULOSPINAL & OLIVOSPINAL. CONTROL OF POSTURE & IN THE INITIATION OF MOVEMENT

11/07/11

MUN FP Academic Half Day

253

EPS LESION

DIFFICULTY IN INITIATING VOLUNTARY MOVEMENT IMPAIRMENT OF ORIENTING & BALANCING REFLEXES. ALTERATION IN MUSCLE TONE STRENGTH IS UNAFFECTED. INVOLUNTARY MOVEMENTS.

11/07/11

MUN FP Academic Half Day

254

CEREBELLUM

RECEIVES AFFERENT FIBRES FROM SPINAL CORD, VESTIBULAR SYSTEM, BASAL GANGLIA & CEREBRAL CORTEX. MODULATE MOVEMENT

11/07/11

MUN FP Academic Half Day

255

CEREBELLAR LESION

ATAXIA VERMIS; TRUNCAL ATAXIA (DIFFICULTY IN SITTING UP OR STANDING) REFLEXES ARE NOT INCREASED.

11/07/11

MUN FP Academic Half Day

256

INTRINSIC CORD LESION


URGE INCONTINENCE /R.O.U DISSOCIATED SENSORY LOSS SPINOTHALAMIC PAIN BILATERAL CORTICOSPINAL TRACT SIGNS PARAPLEGIA & SENSORY LEVEL

11/07/11

MUN FP Academic Half Day

257

SPEECH DEFINITIONS

APHASIA; DISORDER OF LANGUAGE CONTENT OF SPEECH ANOMIA; INABILITY PRODUCE CORRECT WORD PARAPHASIA; PRODUCE NONSENSE WORD

11/07/11

MUN FP Academic Half Day

258

BROCAS APHASIA

MOTOR APHASIA (unable to express) EXPRESSIVE APHASIA NON-FLUENT GOOD COMPREHENSION POOR REPETITION INFERIOR FRONTAL GYRUS LESION LESIONS ANTERIOR TO THE CENTRAL FISSURE

11/07/11

MUN FP Academic Half Day

259

WERNICKES APHASIA

SENSORY RECEPTIVE LOST FLUENT (SPEAK WITHOUT MEANING) POOR COMPREHENSION POOR REPETITION LESIONS POSTERIOR TO THE CENTRAL FISSURE
MUN FP Academic Half Day 260

11/07/11

BRAIN-STEM SYNDROMES

WEBER (ANTERIOR CEREBRAL PEDUNCLE MIDBRAIN) IL3+CL7UMN+CLHP CLAUDE; CEREBRAL PEDUNCLE INVOLVING RED NUCLEUS IL3 + CL CEREBELLAR SIGNS

11/07/11

MUN FP Academic Half Day

261

PARINAUD;

DORSAL MB/ TECTUM VERTICAL GAZE PALSY+ CONVERGENCE DISORDERS + CONVERGENCE RETRACTION+ NYSTAGMUS+ PUPILLARY & LID DISORDERS

11/07/11

MUN FP Academic Half Day

262

MILLARD-GUBLAR;

PONTO-MEDULLARY Jn. IL6+IL7LMN CLHP

11/07/11

MUN FP Academic Half Day

263

WALLENBERG;LATERAL MEDULLARY SYNDROME;

IL5,9,10,11+IL HONER+IL CEREBELLAR+ CL SPINOTHALAMIC VESTIBULAR DISTURBANCE.

11/07/11

MUN FP Academic Half Day

264

DEFINITIONS
CONSCIOUSNESS; IS A STATE OF AWARENESS ONES SELF & ONES ENVIRONMENT SLEEP; IS A STATE OF PHYSICAL & MENTAL INACTIVITY FROM WHICH THE PT. CAN BE AROUSED TO NORMAL CONSCIOUS

11/07/11

MUN FP Academic Half Day

265

DROWSINESS

IS A PATHOLOGICAL STATE THAT RESEMBLES NORMAL SLEEP. PT. CAN BE AROUSED WITH AN EXTERNAL STIMULUS, BUT REVERTS BACK TO HIS DROWSY STATE ON WITHDRAWAL OF STIMULUS

11/07/11

MUN FP Academic Half Day

266

COMA & SEMICOMA


IS THE DEEPEST LEVEL OF UNC. PT. IS IMMOBILE , ALL THE REFLEXES ARE ABSENT AND PLANTAR IS EXTENSOR. SEMICOMA; IS A PATHOLOGICAL STATE, WHICH REQUIRES STRONGER STIMULUS TO AROUSE THE PT., THOUGH HIS REFLEXES ARE NORMAL.

11/07/11

MUN FP Academic Half Day

267

INVOLUNTARY MOVEMENTS

TREMOR; REGULAR & RHYTHMIC OSCILLATORY MOVEMENTS OF AGONIST & ANTAGONIST MUSCLES CHOREA; QUICK, BREIF, SUDDEN, JERKY & IRREGULAR IN TIME, RHYTHM, CHARACTER & PLACE OF OCCRRENCE PROXIMALLY UNDER COVER OF HYPOTONIA

11/07/11

MUN FP Academic Half Day

268

INVOLUNTARY MOVEMENTS

ATHETOSIS; SLOW RHYTHMIC, WRITHING MOVEMENTS DISTALLY & HYPERTONIC. HEMIBALLISMUS; UL, RAPID, CONTINUOUS, INVOLUNTARY MOVEMENTS WITH WIDE EXCURSIONS AFFECTING THE PROXIMAL PARTS OF BODY

11/07/11

MUN FP Academic Half Day

269

INVOLUNTARY MOVEMENTS

DYSTONIA; IT IS AN ABNORMALLY INCREASED MUSCLE TONE THAT CAUSES FIXED ABNORMAL POSTURES OR SHIFTING POSTURES RESULTING FROM IRREGULAR, FORCEFUL TWISTING MOVEMENTS THAT AFFECT THE TRUNK & LIMBS.

11/07/11

MUN FP Academic Half Day

270

INVOLUNTARY MOVEMENTS

FASCICULATIONS; VISIBLE TWITCHES OF HYPEREXCITED MUSCLE FIBRES. IRREGULAR & INCONSISTENT. ABSENT AT REST, FIBRILLATION; CONTRACTION LIMITED TO A SINGLE MUSCLE FIBRE OR A SMALL GROUP OF MUSCLE FIBRES. PRESENT ON TONGUE. SMA, MND, DM, SYPHILIS, SYRINGOMYELIA

11/07/11

MUN FP Academic Half Day

271

TICS OR HABIT SPASMS

INVOLUNTARY STEREOTYPED MOVEMENTS WHICH TO START WITH ARE VOLUNTARY AS THEY SERVE SOME PURPOSE, BUT LATER PERSIST EVENTHOUGH THE STIMULUS THAT INITIATED THE MOVEMENT HAS CEASED.

11/07/11

MUN FP Academic Half Day

272

MYOKIMIA

TRANSIENT OR PERSISTENT QUIVERING FLICKERING MOVEMENTS WHICH AFFECT A FEW MUSCLE BUNDLES WITH IN A SINGLE MUSCLE USUALLY ARE NOT EXTENSIVE ENOUGH TO CAUSE A MOVEMENT.

11/07/11

MUN FP Academic Half Day

273

MYOCLONUS

MYOCLONUS; BRIEF SHOCK-LIKE


MUSCULAR CONTRACTION, WHICH INVOLVE THE WHOLE MUSCLE OR SMALL NUMBER OF MUSCLE FIBRES. IT IS DECREASED BY VOLUNTARY RELAXATION BRIEF, ISOLATED, RANDOM & NONPURPOSEFUL JERKS OF MUSCLE GROUPS IN THE LIMBS.
MUN FP Academic Half Day

11/07/11

274

ASTEREXIS OR FLAPPING TREMOR


INTERMITTENT FAILURE OF PARIETAL MECHANISMS. PT. IS ASKED TO HOLD OUT THE ARMS WITH THE HANDS EXTENDED AT THE WRISTS, THIS POSTURE IS PERIODICALLY DROPPED, ALLOWING THE HANDS TO DROP TRANSIENTLY BEFORE THE POSTURE IS TAKE IT AGAIN.

11/07/11

MUN FP Academic Half Day

275

LMN BLADDER (ATONIC)


S234 LESION LESION OF SACRAL ROOTS & NERVES LOSS OF DETRUSOR CONTRACTION DIFFICULTY INITIATING MICTURITION BLADDER DISTENTION WITH OVERFLOW

11/07/11

MUN FP Academic Half Day

276

HYPERTONIC (UMN)

PYRAMIDAL TACT LESION SPINAL CORD / BRAINSTEM URGENCY / URGE INCONTINENCE BLADDER SPHINCTER INCOORDINATION (DYSSYNERGIA) INCOMPLETE BLADDER EMPTYING
MUN FP Academic Half Day 277

11/07/11

GCS 15 EMV

EYE OPENING; SPONTANEOUS, TO SPEECH, TO PAIN & NIL (4) MOTOR RESPONSE; OBEYS, LOCALIZED, WITHDRAWS, ABNORMAL FLEXION, EXTENSOR RESPONSE & NIL (6) VERBAL RESPONSE; ORIENTED, CONFUSED CONVERSATION, INAPPROPRIATE WORDS, INCOMPREHENSIBLE SOUNDS & NIL (5)

11/07/11

MUN FP Academic Half Day

278

11/07/11

MUN FP Academic Half Day

279

EXTRINSIC CORD LESIONS

ROOT PAIN, WORSENED BY MOVEMENT PROGRESSIVE ASYMMETRICAL PARAPARESIS BSS PARAPLEGIA WITH SENSORY LEVEL INCONTINENCE / RETENSION OF URINE & FAECES
MUN FP Academic Half Day 280

11/07/11

SENSORY DERMATOME ANTERIOR ASPECT


VERTEX; C1 PINNA; C2 NECK; C3 SHOULDER; C4 ARM LATERAL ; C5 MIDDLE ; T1 MEDIAL ; T2 FOREARM LATERAL; C6 MEDIAL ; C8 MIDDLE FINGER ; C7

11/07/11

MUN FP Academic Half Day

281

SENSORY DERMATOME

HAND ; C678 VERTEX / NECK / AXILLA ; C234 ARM / FA POST LATERAL; C5 INNER AXILLARY FOLD; D3 FA POST MEDIAL; D1

11/07/11

MUN FP Academic Half Day

282

SOLE OF FOOT

S1 BULK L5 GREAT TOE REVERSE IN DORSUM OF FOOT L5 BULK S1 LITTLE TOE

11/07/11

MUN FP Academic Half Day

283

ANTERIOR LEG

L2 UPPER THIGH L3 LOWER THIGH L4 UPPER LEG L5 LOWER LEG & FOOT L2,3,4 Knee Jerk

11/07/11

MUN FP Academic Half Day

284

POSTERIOR LEG

S2,3,4 saddle shaped L1,2,3 lateral aspect thigh

11/07/11

MUN FP Academic Half Day

285

Spinal segment related to vertebral body


Cervical vertebrae Thoracic 1 6 Thoracic 7 9 Thoracic 10 Thoracic 11 Thoracic 12 First lumbar arch

: add 1 : add 2 : add 3 : L1 & L2 : L3 & L4 : L5 : sacral & coccygeal segments

11/07/11

MUN FP Academic Half Day

286

Sensory polyneuropathy

Glove and stocking anesthesia Distal parts All modalities lost

11/07/11

MUN FP Academic Half Day

287

Cauda equina and conus lesion


Perianal anesthesia S234 involvement

11/07/11

MUN FP Academic Half Day

288

Brown Sequerd syndrome


Hemi section of cord lesion Ipsi lateral loss pyramidal and posterior columns signs Contra lateral spino thalamic tract signs Band of hyperesthesia

11/07/11

MUN FP Academic Half Day

289

High cord compression


Sacral sparing Loss of all modalities of sensations

11/07/11

MUN FP Academic Half Day

290

Dissociate anesthesia

Central cord lesion Sparing posterior columns Involvement of spino thalamic tracts Syringomyelia & Ketamine

11/07/11

MUN FP Academic Half Day

291

Brain stem syndrome

Loss of spino thalamic tract signs on IPSILATERAL side of face Loss of spino thalamic tract signs on CONTRA LATERAL side of body Involvement of Trigeminal tract or nucleus & lateral spinothalamic tracts.

11/07/11

MUN FP Academic Half Day

292

Thalamic syndrome

Loss of all modalities of sensations on opposite side of the body. Position sense is more affected than any other sensation. There may be spontaneous pain and discomfort (thalamic pain) Torturing and disabling type.

11/07/11

MUN FP Academic Half Day

293

Parietal lobe syndrome


Loss of tactile localization Loss of tactile discrimination Tactile extinction Astereognosis

11/07/11

MUN FP Academic Half Day

294

Anterior spinal syndrome

Anterior spinal artery thrombosis Loss of spino thalamic signs on both sides Preservation of posterior columns

11/07/11

MUN FP Academic Half Day

295

Posterior spinal syndrome


Posterior spinal artery thrombosis Loss of posterior columns on both sides Preservation of spino thalamic signs Noticed in Tabes dorsalis

11/07/11

MUN FP Academic Half Day

296

Causes of Ischemic Stroke


Common Causes Thrombosis
Lacunar stroke (small vessel) Large vessel thrombosis Dehydration

11/07/11

MUN FP Academic Half Day

297

Causes of Ischemic Stroke


Embolic

occlusion

Artery-to-artery
Carotid bifurcation Aortic arch Arterial dissection

11/07/11

MUN FP Academic Half Day

298

Causes of Ischemic Stroke

Cardioembolic

Atrial fibrillation Mural thrombus Myocardial infarction Dilated cardiomyopathy Valvular lesions Mitral stenosis Mechanical valve Bacterial endocarditis Paradoxical embolus Atrial septal defect Patent foramen ovale Atrial septal aneurysm Spontaneous echo contrast

11/07/11

MUN FP Academic Half Day

299

Uncommon Causes
Hypercoagulable

disorders

Protein C deficiency Protein S deficiency Antithrombin III deficiency Antiphospholipid syndrome Factor V Leiden mutationa Prothrombin G20210 mutationa Systemic malignancy

11/07/11

MUN FP Academic Half Day

300

Uncommon Causes
Sickle cell anemia -Thalassemia Polycythemia vera Systemic lupus erythematosus Homocysteinemia Thrombotic thrombocytopenic purpura Disseminated intravascular coagulation Dysproteinemias Nephrotic syndrome Inflammatory bowel disease Oral contraceptives

11/07/11

MUN FP Academic Half Day

301

Uncommon Causes
Venous sinous thrombosis Fibromuscular dysplasia Vasculitis

Systemic vasculitis (PAN, Wegener's, Takayasu's, giant cell arteritis) Primary CNS vasculitis Meningitis (syphilis, tuberculosis, fungal, bacterial, zoster)

11/07/11

MUN FP Academic Half Day

302

Uncommon Causes

Cardiogenic
Mitral valve calcification Atrial myxoma Intracardiac tumor Marantic endocarditis Libman-Sacks endocarditis

Subarachnoid hemorrhage vasospasm Drugs: cocaine, amphetamine Moyamoya disease Eclampsia

11/07/11

MUN FP Academic Half Day

303

Risk Factors for Stroke


Risk Factor Relative Risk Relative Risk Reduction with Treatment Primary Prevention Secondary Prevention Hypertension 2538%10030050100 Atrial fibrillation 1.82.968%warfarin, 21% aspirin 208313 Diabetes1.86No proven effect Smoking1.850% at 1 year, baseline risk at 5 years post cessation Hyperlipidemia1.82.61630%560230 Asymptomatic carotid stenosis2.053%85N/ Asymptomatic carotid stenosis (7099%) 65% at 2 yearsN/A12 Symptomatic carotid stenosis (5069%) 29% at 5 yearsN/A77

11/07/11

MUN FP Academic Half Day

304

Вам также может понравиться